A carregar...
A Review of mTOR Pathway Inhibitors in Gynecologic Cancer
The treatment of advanced gynecologic cancers remains palliative in most of cases. Although systemic treatment has entered into the era of targeted drugs the antitumor efficacies of current therapies are still limited. In this context there is a great need for more active treatment and rationally de...
Na minha lista:
| Publicado no: | Oxid Med Cell Longev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5327776/ https://ncbi.nlm.nih.gov/pubmed/28286604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/4809751 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|